1. Home
  2. DK vs TNGX Comparison

DK vs TNGX Comparison

Compare DK & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

HOLD

Current Price

$34.94

Market Cap

1.8B

Sector

Energy

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$13.51

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DK
TNGX
Founded
2001
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.4B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
DK
TNGX
Price
$34.94
$13.51
Analyst Decision
Hold
Strong Buy
Analyst Count
17
7
Target Price
$35.41
$14.33
AVG Volume (30 Days)
1.3M
2.2M
Earning Date
01-01-0001
04-06-2026
Dividend Yield
2.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$42,069,000.00
Revenue This Year
N/A
$52.63
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.17
52 Week Low
$11.03
$1.04
52 Week High
$43.50
$13.48

Technical Indicators

Market Signals
Indicator
DK
TNGX
Relative Strength Index (RSI) 57.95 63.84
Support Level $29.34 $6.33
Resistance Level $35.45 N/A
Average True Range (ATR) 1.89 0.77
MACD 0.18 -0.04
Stochastic Oscillator 77.89 92.93

Price Performance

Historical Comparison
DK
TNGX

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: